S
Simon Monard
Researcher at Walter and Eliza Hall Institute of Medical Research
Publications - 31
Citations - 4076
Simon Monard is an academic researcher from Walter and Eliza Hall Institute of Medical Research. The author has contributed to research in topics: Cytotoxic T cell & CD8. The author has an hindex of 18, co-authored 29 publications receiving 3966 citations. Previous affiliations of Simon Monard include Los Alamos National Laboratory & Lincoln's Inn.
Papers
More filters
Journal ArticleDOI
Novel Impactor and Microsphere-Based Assay Used to Measure Containment of Aerosols Generated in a Flow Cytometer Cell Sorter.
Stephen P. Perfetto,Phillip J. Hogarth,Simon Monard,Ben Fontes,Kristen M. Reifel,Brandon K. Swan,Jan Baijer,Evan R. Jellison,Geoffrey Lyon,Patty Lovelace,Richard Nguyen,David R. Ambrozak,Kevin L. Holmes +12 more
TL;DR: A novel and replacement method utilizing a Cyclex‐d impactor and Dragon Green beads that was compared for sensitivity of detection of escaped aerosols with a published method for aerosol detection which utilizes aUV‐APS aerodynamic particle sizer and a UV‐excitable dye.
Journal ArticleDOI
Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
Kristen M. Reifel,Brandon K. Swan,Evan R. Jellison,David R. Ambrozak,Jan Baijer,Richard Nguyen,Simon Monard,Geoffrey Lyon,Benjamin Fontes,Stephen P. Perfetto +9 more
TL;DR: Procedures covering the biosafety aspects of sorting unfixed SARS‐CoV‐2‐infected cells and other infectious agents of similar risk level are presented.
Journal ArticleDOI
Spectrum of Reactivity with Three Monoclonal Antibodies-MHM6(CD23), L30(CD24) and UCHB1-in B-Cell Leukaemias.
TL;DR: Cells from patients with a range of B-cell leukaemias have been investigated for reactivity with three monoclonal antibodies-MHM6 (CD23), L30 (CD24) and UCHB1 and observations suggest that these reagents provide useful additional information in the differential diagnosis ofB-lineage lymphoproliferative disorders.
Journal ArticleDOI
Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.
Stefano Mangiola,Patrick McCoy,Patrick McCoy,Martin Modrak,Fernando Souza-Fonseca-Guimaraes,Daniel Blashki,Ryan Stuchbery,Simon P. Keam,Simon P. Keam,Michael Kerger,Ken Chow,Ken Chow,Chayanica Nasa,Melanie Le Page,Natalie Lister,Simon Monard,Justin S. Peters,Phil Dundee,Scott Williams,Scott Williams,Anthony J. Costello,Anthony J. Costello,Paul J Neeson,Paul J Neeson,Bhupinder Pal,Nicholas D. Huntington,Niall M. Corcoran,Niall M. Corcoran,Niall M. Corcoran,Anthony T. Papenfuss,Christopher M. Hovens,Christopher M. Hovens +31 more
TL;DR: In this article, a Bayesian inference model for continuous differential transcript abundance and multiplex immunohistochemistry were used to define the transcriptional landscape of the prostate cancer microenvironment along the disease progression axis.